Last reviewed · How we verify
NCT03752476: INOR Blact
Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria
trial testing number of Beta lactam class prescription for the same infection in Resistant Infection in 1,300 participants. Status unknown.
1 May 2019
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de Besancon |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,300 |
| Start date | 1 January 2019 |
| Primary completion | 1 May 2019 |
| Estimated completion | 1 May 2019 |
Drugs / interventions tested
- number of Beta lactam class prescription for the same infection
Conditions studied
- Resistant Infection — all drugs for Resistant Infection →
- Antibiotic Resistant Infection — all drugs for Antibiotic Resistant Infection →
- Beta Lactam Resistant Bacterial Infection — all drugs for Beta Lactam Resistant Bacterial Infection →
- Bacterial Resistance — all drugs for Bacterial Resistance →
Sponsor
Centre Hospitalier Universitaire de Besancon
Who can join
Adults 18 to 100, any sex, with Resistant Infection or Antibiotic Resistant Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the impact of rank of Beta lactam antibiotics on emergence of mutlidrug resistant bacteria colonization in intensive care It's retrospective case controle study. Cases are colonized patient by multidrug resistant bacteria hospitalized in intensive care during the fist hospitalization in intensive care. Temoin are patients with the same characteristics than case but no colonized by multidrug resistant bacteria.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03752476
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Resistant Infection
Currently open trials in the same condition.
- NCT05482763 — Mycosis Culture Collection From Dermatological Isolated · active not recruiting
Other Centre Hospitalier Universitaire de Besancon trials
Trials by the same sponsor.
- NCT07492199 — High Depth Exome Sequencing on DNA From a Salivary Sample by Mouth Smear. · not yet recruiting
- NCT07438015 — VEXUS-REA : Evaluation of Ultrasound Parameters of Venous Congestion in Patients in a Medical Intensive Care Unit · NA · not yet recruiting
- NCT06796114 — Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Du · NA · recruiting
- NCT06864065 — Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder · NA · recruiting
- NCT07067762 — Botulinum Toxin Injections Into the Salivary Glands of Cerebrospinal Children With Chronic Sialorrhea · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03752476 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Besancon
- Last refreshed: 26 November 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03752476.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing